Presence of antiphospholipid antibody is a risk factor in thrombotic events in patients with antiphospholipid syndrome or relevant diseases

被引：13

作者：

Habe, Koji ^{[1
]}

Wada, Hideo ^{[2
]}

Matsumoto, Takeshi ^{[3
]}

Ohishi, Kohshi ^{[3
]}

Ikejiri, Makoto ^{[2
]}

Matsubara, Kimiko ^{[1
]}

Morioka, Tatsuhiko ^{[1
]}

Kamimoto, Yuki ^{[4
]}

Ikeda, Tomoaki ^{[4
]}

Katayama, Naoyuki ^{[5
]}

Nobori, Tsutomu ^{[2
]}

Mizutani, Hitoshi ^{[1
]}

机构：

[1] Mie Univ, Grad Sch Med, Dept Dermatol, Tsu, Mie 5148507, Japan

[2] Mie Univ, Grad Sch Med, Dept Mol & Lab Med, Tsu, Mie 5148507, Japan

[3] Mie Univ, Grad Sch Med, Dept Blood Transfus, Tsu, Mie 5148507, Japan

[4] Mie Univ, Grad Sch Med, Dept Obstet & Gynecol, Tsu, Mie 5148507, Japan

[5] Mie Univ, Grad Sch Med, Dept Hematol & Oncol, Tsu, Mie 5148507, Japan

来源：

INTERNATIONAL JOURNAL OF HEMATOLOGY | 2013年 / 97卷 / 03期

基金：

日本学术振兴会;

关键词：

APS; Thrombosis; aPL; LA; beta 2-Glycoprotein I; SYSTEMIC-LUPUS-ERYTHEMATOSUS; THROMBOCYTOPENIC PURPURA; ANTICOAGULANT LA; PREVALENCE; GUIDELINES; MANAGEMENT; DIAGNOSIS;

D O I：

10.1007/s12185-013-1277-0

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Antiphospholipid antibodies (aPL) including lupus anticoagulant (LA), anticardiolipin antibodies (aCL) IgG and aCL-beta 2-glycoprotein I (beta 2GPI) complex IG are causative factors for thrombotic event (THE). We retrospectively investigated relationships between aPLs and THE in 458 patients suspected of having antiphospholipid syndrome. THEs were observed in 232 of 458 patients, including 148 cases of venous thrombosis, 59 of arterial thrombosis, 18 of microthrombosis, and 20 of complications of pregnancy. The frequency of THE was significantly high in patients positive for LA and/or aPL. In patients with autoimmune disease (AID), the frequency of THE was significantly high in patients with any types of aPLs. Additionally, risk of THE was significantly increased in patients with more than two types of aPLs. Prolonged activated partial thromboplastin time indicated a high risk for THE. However, neither thrombocytopenia nor AID was a risk for THE. In conclusion, the presence of aPL is an indicator for high risk of THE in patients in whom THE was suspected. However, the risk of THE in aPL-positive patients varied among patients with different underlying diseases.

引用

页码：345 / 350

页数：6

共 50 条

[21] Antiphospholipid antibody syndrome [J].

Yang, Paul ;

Kruh, Jonathan N. ;

Foster, C. Stephen .

CURRENT OPINION IN OPHTHALMOLOGY, 2012, 23 (06) :528-532

[22] Thrombotic Primary Antiphospholipid Syndrome: the profile of antibody positivity in patients from North India [J].

Ahluwalia, Jasmina ;

Sreedharanunni, Sreejesh ;

Kumar, Narender ;

Masih, Joseph ;

Bose, Sunil Kumar ;

Varma, Neelam ;

Varma, Subhash ;

Singh, Surjit .

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2016, 19 (09) :903-912

[23] Current clinical and laboratory practice for the investigation of the antiphospholipid syndrome: findings from the 2008 Australasian antiphospholipid antibody survey [J].

Favaloro, Emmanuel J. ;

Wong, Richard C. W. .

PATHOLOGY, 2009, 41 (07) :666-675

[24] The first thrombotic event in purely obstetric antiphospholipid syndrome patients and in antiphospholipid antibody carriers: comparison of incidence and characteristics [J].

Marta Tonello ;

Antonia Calligaro ;

Maria Favaro ;

Teresa Del Ross ;

Paola Veronese ;

Elisa Salvan ;

Maria Teresa Gervasi ;

Amelia Ruffatti .

Archives of Gynecology and Obstetrics, 2021, 303 :455-461

[25] The first thrombotic event in purely obstetric antiphospholipid syndrome patients and in antiphospholipid antibody carriers: comparison of incidence and characteristics [J].

Tonello, Marta ;

Calligaro, Antonia ;

Favaro, Maria ;

Del Ross, Teresa ;

Veronese, Paola ;

Salvan, Elisa ;

Gervasi, Maria Teresa ;

Ruffatti, Amelia .

ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2021, 303 (02) :455-461

[26] Impact of antiphospholipid antibodies on thrombotic events in ambulatory cancer patients [J].

Kansuttiviwat, Chalermkiat ;

Niprapan, Piangrawee ;

Tantiworawit, Adisak ;

Norasetthada, Lalita ;

Rattarittamrong, Ekarat ;

Rattanathammethee, Thanawat ;

Hantrakool, Sasinee ;

Piriyakhuntorn, Pokpong ;

Punnachet, Teerachat ;

Hantrakun, Nonthakorn ;

Chai-Adisaksopha, Chatree .

PLOS ONE, 2023, 18 (01)

[27] Laboratory testing for the antiphospholipid syndrome: making sense of antiphospholipid antibody assays [J].

Favaloro, Emmanuel J. ;

Wong, Richard C. W. .

CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 (03) :447-461

[28] Is there a link between mean platelet volume and thrombotic events in antiphospholipid syndrome? [J].

Korkmaz, Serdal ;

Uslu, Ali Ugur ;

Sahin, Safak ;

Senel, Soner ;

Sencan, Mehmet .

PLATELETS, 2014, 25 (05) :343-347

[29] Thrombotic events in patients with antiphospholipid syndrome treated with rivaroxaban: a series of eight cases [J].

Signorelli, Flavio ;

Nogueira, Felipe ;

Domingues, Vinicius ;

Mariz, Henrique Ataide ;

Levy, Roger A. .

CLINICAL RHEUMATOLOGY, 2016, 35 (03) :801-805

[30] Thrombotic manifestations of the antiphospholipid syndrome in patients with malignancies [J].

Miesbach, Wolfgang ;

Scharrer, Inge ;

Asherson, Ronald .

CLINICAL RHEUMATOLOGY, 2006, 25 (06) :840-844

← 1 2 3 4 5 →